ANDREW PORTER: Open Payments
NPI 1801826094 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,815 in 103 payments from 32 companies in 2025. Trend: 2023 $421 · 2024 $1,840 · 2025 $1,815
Food & beverage: $1,815
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $208 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $153 |
| Amgen Inc. | 12 | $151 |
| Novo Nordisk Inc | 10 | $139 |
| PFIZER INC. | 8 | $135 |
| Lilly USA, LLC | 5 | $123 |
| Sumitomo Pharma America, Inc. | 4 | $89 |
| Abbott Laboratories | 4 | $89 |
| GlaxoSmithKline, LLC. | 4 | $82 |
| Exact Sciences Corporation | 3 | $66 |
Products named: Kerendia, MOUNJARO, NURTEC ODT, GEMTESA, FREESTYLE LIBRE 3, Ozempic, TRELEGY ELLIPTA, OTEZLA.
Industry payments across AZ — which companies pay providers there.
